Data Stories
Where healthtech exits are going.
594 verified exits and counting — the deals shaping how healthtech companies sell, and who is buying.
Read the data →The Benefit Cuts Beneath Medicare Advantage
Plans cut benefits before the final rule arrived. We tracked the filings.
OptionsMD
AI telepsychiatry for treatment-resistant illness. The founder ran the sale himself and signed from a hospital NICU. Acquired by Resilience Lab in 2024.
Avhana Health
Clinical decision support built inside the EMR. Acquired by AmalgamRx in 2021 after a two-buyer process.
The Seven Diligence Gates for M&A
Where buyers make go or no-go decisions, and what to have ready at each one.
Read the report →QueueDr
EHR-native scheduling automation deep enough that incumbents couldn't replicate it. Acquired by Phreesia in 2021.
Market Forces Driving Healthtech M&A in 2026
Five forces shaping which healthtech companies close deals and which ones stall.
Read the report →Fetal Pillow
A device for the impacted fetal head during C-sections. Bootstrapped, team of three. Acquired by CooperSurgical in 2021.
Exit Scenario Model
How to take on capital without giving away your leverage. Three scenarios from Series A through Series C.
Download the model →New findings, in your inbox, before they're anywhere else.
A short note when we publish. Deal patterns, exit mechanics, and the numbers behind them. No noise.
Read by PE, corp dev, and banking teams. Unsubscribe anytime.